Jersey R&O 48/2002
Health Insurance (Jersey)
Law 1967
____________
HEALTH
INSURANCE (PHARMACEUTICAL BENEFIT) (GENERAL PROVISIONS) (No. 2) (JERSEY) ORDER 2002
____________
1. Interpretation
2. Approval of suppliers
3. Terms and conditions
of supply of pharmaceutical benefit
4. Schemes for securing
proper pharmaceutical services
5. Prescribed form for
the supply of pharmaceutical benefit
6. Period of supply
7. Supply
8. Offences
9. Prescription costs
payable by the Committee
10. Revocation
11. Citation and
commencement
SCHEDULES
Schedule 1 - Approval of suppliers of pharmaceutical
benefit
Schedule 2 - Part
1 Terms and conditions to be observed
by an approved supplier
Part 2 Form of notice to be displayed by an
approved supplier who is a person lawfully conducting a retail pharmacy
business
Part 3 Form of notice to be displayed by an
approved supplier other than a person lawfully conducting a retail pharmacy
business
Part 4 Form of notice to be displayed by an
approved supplier who is a person lawfully conducting a retail pharmacy
business at times when his premises are closed
Schedule 3 - Form of prescription
Schedule 4 - Pharmaceutical
benefit which may be supplied for 90 days on any one prescription signed by an
approved medical practitioner
Schedule 5 - Dispensing fees
Schedule 6 - Reduction of amount payable to approved
suppliers
Health Insurance (Jersey)
Law 1967
____________
HEALTH INSURANCE (PHARMACEUTICAL BENEFIT) (GENERAL PROVISIONS) (No.
2) (JERSEY) ORDER 2002
____________
THE EMPLOYMENT AND SOCIAL
SECURITY COMMITTEE, in pursuance of Articles 24, 26
and 46 of the Health Insurance (Jersey) Law 1967, as amended, orders as follows -
Interpretation
1.-(1) In this
Order, unless the context otherwise requires -
“Drug Tariff” means the statement compiled and published by the
Secretary of State for Health of the United Kingdom pursuant to Regulation 18(1)
of the National Health Service (Pharmaceutical Services) Regulations 1992, as
that statement is for the time being in force;
“Health Card” means an Identity Card issued in accordance with the
Health Insurance (Evidence) (Jersey) Order
1967;
“Law” means the Health Insurance (Jersey)
Law 1967, as amended;
“prescription” has the same meaning as given to the expression
“prescribed form” by Article 5.
(2) In this Order, unless the context otherwise
requires -
(a) a reference to an enactment (including an instrument made under
any enactment of the Parliament of the United Kingdom) shall be taken to
be a reference to -
(i) that enactment as from time to time
amended or extended or applied by or under another enactment, and
(ii) any other enactment repealing and
re-enacting that enactment with or without any further amendment;
(b) a reference to an Article or Schedule by number only is a
reference to the Article or Schedule of that number contained in this Order;
(c) a reference in an Article or other division of this Order to a
paragraph, sub-paragraph, clause or item by number or letter only is a
reference to the paragraph, sub-paragraph, clause or item of that number or
letter contained in the Article or other division of this Order in which it
appears.
Approval of suppliers
2.-(1) An
application by a person conducting a retail pharmacy business for approval
under Article 35(2) of the Law as a supplier of pharmaceutical benefit must be substantially in
the form set out in Part 1 of Schedule 1.
(2) An application by any other person for that
approval must be substantially in the form set out in Part 2 of Schedule 1.
Terms
and conditions of supply of pharmaceutical benefit
3. For the purpose of Article 35(2) and (3) of the Law6 the terms and conditions a person in an application for approval as
an approved supplier must undertake to supply pharmaceutical benefit on are
those set out in Part 1 of Schedule 2.
Schemes for securing
proper pharmaceutical services
4.-(1) The Committee may act in accordance with paragraph
(2) if at any time it is satisfied that there is an insufficient number of
places of business of approved suppliers open outside normal business hours.
(2) The Committee may after consulting the
Pharmaceutical Benefit Advisory Committee prepare a scheme designed to ensure
that a sufficient number of places of business of approved suppliers are open
at reasonable times outside normal business hours.
(3) The scheme must -
(a) specify the days and hours during which places of business of
approved suppliers are to be open; and
(b) provide for payments to be made to those suppliers in respect of
periods during which their premises are open under the scheme.
Prescribed form for the
supply of pharmaceutical benefit
5.-(1) For the
purposes of Article 24(1A) of the Law “prescribed form” means a form substantially in the form set out in
Schedule 3 that -
(a) contains the particulars required to
complete the form;
(b) is dated with the date on which it is to become effective;
(c) is signed by the approved medical practitioner or dentist that
gave the form;
(d) is printed on white paper if signed by a medical practitioner
and on yellow paper if signed by a dentist; and
(e) is watermarked with a design designated by the Committee.
(2) A form is not in the prescribed form if it
authorizes the supply of pharmaceutical benefit for more than one person.
Period of supply
6.-(1) An
approved medical practitioner or dentist must not give a prescription that
orders the supply of pharmaceutical benefit necessary to provide treatment for
a person for a period exceeding 30 days.
(2) Despite paragraph (1) an approved medical
practitioner may give a prescription that orders the supply of pharmaceutical
benefit necessary to provide treatment for a person for a period exceeding 30
days but not exceeding 90 days if the pharmaceutical benefit is of a type
specified in Schedule 4.
(3) An approved medical practitioner or dentist
must not give more than one prescription in respect of the same pharmaceutical
benefit at any one time.
(4) Despite paragraph (3) an approved medical
practitioner or dentist may give more than one but not more than four
prescriptions in respect of the same pharmaceutical benefit at any one time if
the prescriptions authorize consecutive periods of supply of pharmaceutical
benefit to a person.
(5) Where an approved medical practitioner or
dentist has given a prescription or prescriptions in respect of a period of
treatment of a person the practitioner or dentist must not during that period
of treatment give a further prescription in respect of that person for the same
pharmaceutical benefit unless the practitioner or dentist is satisfied that it
is necessary or desirable to do so for the purpose of the treatment and -
(a) the pharmaceutical benefit is intended for the continuation of
the treatment after the expiry of the present period of treatment and the
prescription bears a date not earlier than 21 days before the end of that
period;
(b) the prescription is for an increase in
dosage; or
(c) the prescription is to replace pharmaceutical benefit previously
supplied on prescription and accidentally lost or destroyed.
(6) An approved supplier must not supply
pharmaceutical benefit ordered on a prescription before the effective date of
the prescription.
Supply
7.-(1) This
Article applies where in accordance with a prescription pharmaceutical benefit
is supplied by an approved supplier in respect of an insured person or a
dependant of an insured person.
(2) The person to whom the pharmaceutical
benefit is supplied must produce and show to the approved supplier the insured
person’s Health Card.
(3) Subject to paragraph (4) -
(a) the person to whom the pharmaceutical benefit is supplied must
surrender the prescription to the approved supplier; and
(b) the approved supplier must mark on the prescription the health
insurance number specified on the insured person’s Health Card.
(4) The person taking delivery of
pharmaceutical benefit is not required to surrender the prescription if by an
electronic means the approved medical practitioner or dentist that signed the
prescription -
(a) notifies the approved supplier of the particulars contained in
the prescription and its effective date;
(b) confirms that the prescription is signed by the doctor or
dentist; and
(c) undertakes to surrender the prescription to the approved
supplier within 72 hours of the notification,
and the approved supplier is satisfied that, by reason of an emergency,
the practitioner or dentist has been unable to furnish the person taking
delivery of the pharmaceutical benefit with the prescription so that it is
available for surrender at the time of delivery.
(5) Except as provided in paragraphs (6) and (7),
the person taking delivery of the pharmaceutical benefit must pay the approved
supplier a prescription charge of £1.95 for each item of pharmaceutical benefit
supplied.
(6) The person taking delivery of the
pharmaceutical benefit must pay the approved supplier a prescription charge of
65p for each item of pharmaceutical benefit supplied if -
(a) the pharmaceutical benefit is of a type described in Part 1 of
Schedule 4;
(b) the prescription is signed by an authorized medical
practitioner; and
(c) the supply ordered by any one prescription is only sufficient to
provide treatment for a person for a period not exceeding 30 days.
(7) The approved supplier shall not require the
person taking delivery of the pharmaceutical benefit to pay a prescription
charge if the person produces and shows to the approved supplier a current
Health Insurance Exception card issued by the Employment and Social Security
Department to the insured person.
(8) Where paragraph (7) applies the approved
supplier must endorse the prescription with the notation “HIE”.
Offences
8.-(1) Except
as provided by paragraph (2), a person who fails to comply with a provision of
this Order shall be guilty of an offence and liable to a fine not exceeding
level 2 on the standard scale.
(2) A person who fails to surrender a
prescription as required under Article 7(3)(a) is liable to a fine not
exceeding level 1 on the standard scale.
Prescription costs payable
by the Committee
9.-(1) Except
as otherwise provided by this Article, the amount to be paid by the Committee
to an approved supplier for each item of pharmaceutical benefit supplied on a
prescription in respect of an insured person or a dependant of an insured
person is the sum of the following -
(a) the basic price of the ingredients; and
(b) the appropriate dispensing fee or fees as set out in
Schedule 5.
(2) The aggregate amount payable to an approved
supplier under paragraph (1)(a) in respect of pharmaceutical benefit supplied
in any month shall be reduced in accordance with the scale set out in the
Schedule 6.
(3) Despite paragraph (2) a reduction shall not
be made in respect of any item supplied by an approved suppler that is
specified in the “ZD List” in the Drug Tariff if the approved supplier -
(a) purchased the item at a price not less than its basic price as
calculated in accordance with the Drug Tariff; and
(b) has endorsed the prescription with the
notation “ZD”.
(4) In the circumstances specified in paragraph
(5) the amount to be paid to the approved supplier under paragraph (1) shall be
the amount that would be payable under that paragraph if each instalment
referred to in paragraph (5) had been supplied on a separate prescription.
(5) The circumstances referred to in paragraph
(4) are where an approved supplier supplies by way of pharmaceutical benefit a
substance or product in accordance with a prescription signed by a approved
medical practitioner that specifies that it is to be supplied in instalments at
stipulated intervals or on given dates, and -
(a) the substance or product at the time of supply is specified in
Part I, II or III of the Second Schedule to the Misuse of Drugs (Jersey) Law 1978; and
(b) the person for whom the supply is ordered has been the subject
of notification to the Medical Officer of Health pursuant to the Misuse of
Drugs (Addicts) (Jersey) Order 1980.
(6) Where an approved supplier supplies
pharmaceutical benefit on a prescription any amount that the supplier receives
or should have received under Article 7(5) or (6) is to be deducted from the
amount payable to the supplier in respect of the pharmaceutical benefit.
(7) For the purposes of this Article the basic
price of an ingredient is its basic price calculated in accordance with the
Drug Tariff as at the date of its supply.
(8) If the term “aqua” is used in a
prescription without qualification the approved supplier shall -
(a) interpret it to mean wholesome drinking
water; and
(b) not charge for it.
(9) An approved supplier shall not charge for
distilled water unless -
(a) its use is specified on the prescription;
or
(b) it is necessary to use distilled water to conform with standard
dispensing practice.
Revocation
10. The Health Insurance (Pharmaceutical
Benefit) (General Provisions) (Jersey) Order
2002 is revoked.
Citation
and commencement
11. This
Order may be cited as the Health Insurance (Pharmaceutical Benefit) (General
Provisions) (No. 2) (Jersey) Order 2002
and comes into force on 1st October 2002.
By Order of the
Employment and Social Security Committee,
C.M.
NEWCOMBE
Greffier of the States.
6th June 2002.
SCHEDULE 1
(Article 2)
APPROVAL OF SUPPLIERS OF PHARMACEUTICAL BENEFIT
PART 1
Health
Insurance (Jersey) Law 1967
Form of application for approval as supplier of pharmaceutical
benefit of person(s) lawfully conducting a retail pharmacy business
To: The Employment and Social Security Committee
I/We, .......................................................................................................
of ..............................................................................................................................
being a person or persons lawfully conducting a
retail pharmacy business within the meaning of the Medicines (Jersey)
Law 1995, apply for approval in accordance with Article 35(2) of the Health
Insurance (Jersey) Law 1967. I/we undertake to
dispense medicines and supply drugs at the prices fixed and in accordance with
the terms and conditions prescribed under the Health Insurance (Jersey) Law
1967. I/we understand that those prices, terms and conditions are subject to
variation in the manner provided by that Law.
The address(es) of my/our business premises
registered in accordance with the Medicines (Jersey)
Law 1995 and the pharmacist(s) in charge of those premises will be as follows -
Address(es) of premises
|
Full name(s) of pharmacist(s) in
charge
|
|
|
Signed: ................................................................................
Date: ....................................................................................
PART 2
Health Insurance (Jersey) Law 1967
Form of application for
approval as supplier of pharmaceutical benefit of person(s) other than
person(s) lawfully conducting a retail pharmacy business
To: The Social Security Committee
I/We
........................................................................................................
of ..............................................................................................................................
apply for
approval in accordance with Article 35(3) of the Health Insurance (Jersey) Law 1967. I/we hereby undertake to supply drugs
(except poisons in Part I of the Poisons List set out in the Schedule to the
Poisons List (Jersey) Order 1986) at the prices fixed and in accordance with
the terms and conditions prescribed under the Health Insurance (Jersey) Law
1967. I/we understand that the those prices, terms and conditions are subject
to variation in the manner provided by that Law.
The address(es) of my/our business premises for
this purpose will be
Signed: ....................................................................
Date: ........................................................................
SCHEDULE 2
(Article 3)
PART 1
TERMS AND CONDITIONS TO BE OBSERVED BY AN APPROVED SUPPLIER
Supplier
to supply pharmaceutical benefit
1.-(1) The
supplier must supply pharmaceutical benefit with reasonable promptness to a
person who presents a prescription for them.
(2) Sub-paragraph (1) does not require a
supplier to supply a pharmaceutical benefit that the supplier does not
ordinarily supply.
(3) If under this paragraph a supplier is
required to supply a medicine or drug the supplier must supply the medicine or
drug in a suitable container being -
(a) in relation to capsules, tablets, pills or any other medicine or
drug in solid form (other than those prepacked in foil or paper-board or strip
card containers by the manufacturer) - an airtight container of glass,
aluminium or rigid plastic;
(b) in relation to ointments, creams or pastes (other than those
prepacked by the manufacturer) - a container of glass, aluminium or rigid
plastic;
(c) in relation to eye, ear or nasal drops (other than those
prepacked by the manufacturer) - a container of glass either incorporating or
having a separate dropper attachment;
(d) in relation to liquid medicines (other than those prepacked by
the manufacturer) - a container of glass or rigid plastic, including, in the
case of an oral liquid medicine, a 5 ml. plastic measuring spoon (unless the
patient already has one or the manufacturer’s pack includes one).
(4) The supplier must not give, promise or
offer a gift or a reward as an inducement to or in consideration of a person
presenting a prescription to the supplier.
Place and hours of
business
2.-(1) The
supplier must supply pharmaceutical benefit at the place or places of business
specified in the supplier’s application for approval under Article 35 of the
Law.
(2) The supplier must keep that place or those
places open for the supply of pharmaceutical benefit -
(a) during normal business hours; and
(b) on the days and during the hours specified in any scheme made by
the Committee under Article 4.
(3) At each such place of business the supplier
must display a notice to be provided by the Committee in the form set out in
Part 2 or Part 3 of this Schedule.
(4) If the supplier is a person lawfully
conducting a retail pharmacy business the supplier must also display a notice
to be provided by the Committee in the form set out in Part 4 of this Schedule
when the supplier’s place of business is closed.
(5) The notice must indicate -
(a) the addresses of other people lawfully conducting a retail
pharmacy business where medicines and drugs may be obtained; and
(b) the times when they may be obtained at
those premises.
(6) Each notice must be displayed in a manner
that makes it easily visible to members of the public.
Dispensing medicines
3. The supplier must ensure that the supply of medicines on
prescriptions is performed by or under the direct supervision of a pharmacist.
Names of pharmaceutical
chemists
4. Whenever required to do so by the Committee the supplier must
furnish to the Committee the name of each pharmacist employed by the supplier
in dispensing medicines on prescription.
Charges
5. Except for charges that are required or authorized to be made
by this or any other Order made under the Law the supplier must supply a
pharmaceutical benefit and any container free of charge.
Advertising
6.-(1) The
supplier must not advertise either directly or by implication that the supplier
is an approved supplier or that the supplier provides or is authorized to
provide pharmaceutical benefit.
(2) Despite sub-paragraph (1) the supplier may
-
(a) display a notice required by paragraph 2;
(b) include in an advertisement a statement of the days and hours at
which pharmaceutical benefit is supplied.
Information to be provided
7.-(1) This
paragraph does not apply except where the Committee requires information to
determine the amount payable under Article 10 to the supplier for
pharmaceutical benefit supplied by the supplier.
(2) The supplier must furnish to the Committee
or to such person or body as the Committee directs information that the
Committee requires concerning so much of the supplier’s business that relates
to the supply of pharmaceutical benefit.
(3) The supplier must permit a person authorized in writing to do so
by the Committee to conduct surveys at each place of business at or from which
the supplier supplies pharmaceutical benefit.
Payment
8.-(1) On dates specified by the Committee the supplier
must furnish to the Committee or to such person or body as the Committee
directs the prescriptions on which pharmaceutical benefit has been supplied by
the supplier.
(2) The prescriptions must be arranged in the manner the Committee
directs and must be accompanied by a declaration.
(3) The declaration must contain such particulars relating to the
supply by the supplier of pharmaceutical benefit and the receipt of
prescription charges as the Committee specifies.
Withdrawal
9. If the supplier wishes to
cease to be an approved supplier the supplier must give at least 3 months
written notice to the Committee (or such shorter notice as the Committee may
agree) that the supplier no longer wishes to supply pharmaceutical benefit.
PART 2
FORM OF NOTICE TO BE DISPLAYED BY AN APPROVED SUPPLIER WHO IS A
PERSON LAWFULLY CONDUCTING
A RETAIL PHARMACY BUSINESS
Health
Insurance Scheme
(Name of approved supplier)
Approved under the Health
Insurance (Jersey) Law 1967 to dispense medicines and supply drugs.
These premises are open at the
following times -
PART 3
FORM OF NOTICE
TO BE DISPLAYED BY AN APPROVED SUPPLIER OTHER THAN A PERSON LAWFULLY
CONDUCTING A
RETAIL PHARMACY BUSINESS
Health Insurance Scheme
(Name of
approved supplier)
Approved under the Health Insurance (Jersey) Law 1967
to supply drugs (except poisons in Part I of the Poisons List set out in the
Schedule to the Poisons List (Jersey) Order 1986).
These premises
are open at the following times -
PART 4
FORM OF NOTICE
TO BE DISPLAYED BY AN APPROVED SUPPLIER WHO IS A PERSON LAWFULLY CONDUCTING
A RETAIL
PHARMACY BUSINESS AT TIMES WHEN HIS PREMISES ARE CLOSED
Health Insurance Scheme
When these
premises are closed, medicines and drugs may be obtained at the addresses and
times shown below -
SCHEDULE 3
(Article 5)
Form of prescription
Front
HEALTH
INSURANCE PRESCRIPTION FORM
|
|
Supplier’s
Stamp
|
Age
D. o B.
if under 16
|
Name
(including foreme) and address
|
|
Approved
Supplier Endorsement
|
No.
of days treatment
NB
Ensure dose is stated
|
|
N.P.
|
FOR USE BY P.P.A.
|
|
|
|
Signature of doctor
|
Date
|
|
|
Items
|
Health
Insurance Number (see Notes overleaf)
|
Form H9
|
|
Charges
|
|
|
|
|
|
|
|
|
|
|
|
Back
|
NOTES FOR PATIENT
This Prescription Form is issued
under the authority of the States of Jersey Employment and Social Security
Committee and may be taken to any Approved Pharmacist Supplier on the
Employment and Social Security Register.
Medicines urgently required may be
obtained outside of normal business hours if the prescription is marked
“URGENT” and signed by the Doctor or Dentist.
REMEMBER
Your Health Card must be produced
when first presenting this prescription to the Approved Pharmacist Supplier.
|
|
SCHEDULE 4
(Articles 6(2))
Pharmaceutical benefit
which may be supplied for 90 days on any one prescription signed by an approved
medical practitioner
PART 1
Name
of drug and form
|
|
Other
name
|
|
|
|
A.
Anticonvulsants
|
|
|
|
|
|
Acetazolamide
|
Tablets 250 mg
|
Diamox
|
|
Capsules CR
|
|
|
|
|
Carbamazepine
|
Tablets 100 mg;
|
Tegretol
|
|
200 mg; 400 mg
|
|
|
Tablets M.R. 200 mg;
|
|
|
400 mg
|
|
|
Syrup 100 mg per 5 ml
|
|
|
|
|
Clonazepam
|
Tablets 0.5 mg; 2 mg
|
Rivotril
|
|
|
|
Diazepam
|
Rectal tubes
|
|
|
|
|
Ethosuximide
|
Capsules 250 mg
|
Zarontin
|
|
Syrup 250 mg per 5 ml
|
|
|
|
|
Lamotrigine
|
Tablets 25 mg; 50 mg;
|
|
|
100 mg; 200 mg
|
|
|
Dispersible Tablets 2 mg;
|
|
|
5 mg; 25 mg; 100 mg
|
|
|
|
|
Phenobarbitone
|
Tablets 15 mg; 30 mg;
|
|
|
60 mg; 100 mg
|
|
|
Elixir B.N.F.
|
|
|
|
|
Phenobarbitone
|
|
|
Sodium
|
Tablets 30 mg; 60 mg
|
|
|
|
|
Phenytoin
|
Capsules 25 mg; 50 mg;
|
Epanutin
|
|
100 mg
|
|
|
Infatabs 50 mg
|
|
|
Suspension 30 mg per
|
|
|
5 ml
|
|
|
Tablets 50 mg; 100 mg
|
|
|
|
|
Primidone
|
Tablets 250 mg
|
Mysoline
|
|
|
|
Sodium Valproate
|
Syrup 200 mg per 5 ml;
|
Epilim
|
|
Tablets enteric coated
|
|
|
200 mg; 500 mg
|
|
|
Tablets and Crushable
|
|
|
100 mg
|
|
|
Tablets MR 200 mg;
|
|
|
300 mg; 500 mg
|
|
|
Sugar free liquid 200 mg
|
|
|
per 5 ml
|
|
|
|
|
|
B. Preparations for the management of diabetes
|
|
Clinitest
|
Tablets
|
|
|
|
|
Glibenclamide
|
Tablets 2.5 mg; 5 mg
|
Daonil
|
|
|
Semi-Daonil
|
|
|
Euglucon
|
|
|
|
Gliclazide
|
Tablets 80 mg
|
Diamicron
|
|
|
|
Glucagen
|
Injection Kit 1 mg
|
|
|
|
|
Insulin preparations
|
All standard insulins
|
|
|
All highly fortified
|
|
|
insulins
|
|
|
All pro-insulin freed
|
|
|
insulins
|
|
|
|
|
Metformin
|
Tablets 500 mg;
850 mg
|
Glucophage
|
|
|
|
Rosiglitazone
|
Tablets 4 mg; 8 mg
|
|
|
|
|
Tolbutamide
|
Tablets 500 mg
|
|
|
|
|
|
|
|
C.
Thyroid and antithyroid drugs
|
|
Carbimazole
|
Tablets 5 mg
|
Neo-Mercazole
|
|
|
|
Liothyronine
|
|
|
Sodium
|
Tablets 20 mcg
|
Tertroxin
|
|
|
|
Thyroxine Sodium
|
Tablets 25 mcg;
|
Eltroxin
|
|
50 mcg; 100 mcg
|
|
PART 2
Name
of drug and form
|
|
Other
name
|
Didronel PMO Tablets
|
|
|
SCHEDULE 5
(Article
9(1)(b))
Dispensing fees
|
|
Fee in pence for each item of pharmaceutical benefit
supplied on a prescription
|
1.
|
Basic dispensing fee
|
259
|
2.
|
Additional dispensing fees
|
|
|
(a) Preparations
when dispensed extemporaneously and endorsed ‘Extemporaneously dispensed’ -
|
|
|
(i) unit dosage forms, e.g. cachets,
capsules, pills, lozenges, pastilles, pessaries, powders
|
256
|
|
(ii) liquids, being ‘special formula
preparations’, e.g. mixtures, lotions, nasal drops (not including dilutions)
|
155
|
|
(iii) liquid preparations, prepared by
straightforward dilution (not including reconstitution)
|
85
|
|
(iv) special formula powders
|
155
|
|
(v) ointments, creams, pastes, being ‘special
formula preparations’ (not including dilutions)
|
310
|
|
(vi) ointments, creams, pastes, prepared by
dilution or admixture of standard or proprietary ointments, creams and pastes
|
155
|
|
(b) Preparations
when aseptically dispensed and endorsed ‘Aseptically dispensed’ (excluding
proprietary preparations) -
|
|
|
(i) unit dosage forms, e.g. injections
|
1277
per ten or part thereof
|
|
(ii) non-unit
dosage forms, e.g. eye drops
|
767
|
|
(c) Liquid
preparations dispensed extemporaneously other than items (a)(iii) and (b)
above which are ordered by the approved medical practitioner or registered
dentist to be supplied in more than one container, each extra quantity
ordered
|
128
|
|
(d) A
preparation which requires the addition of a vehicle/diluent by the approved
supplier, and results in a liquid of stability of less than fourteen days,
and for pharmaceutical reasons necessitates supply in more than one container
and the prescription is endorsed with the number of extra quantities
supplied, for each extra supply
|
155
|
|
(e) Controlled
drug, as defined in Article 3 of the Misuse of Drugs (Jersey)
Law 1978, and where the prescription is endorsed ‘C.D.’ by the approved
supplier
|
128
|
|
(f) When
the prescription has been dispensed at a time when the premises are not open
for dispensing on the day or (in the case of a prescription dispensed after
midnight) the day following that on which it was written and -
|
|
|
(i) is endorsed ‘URGENT’ by the approved
medical practitioner or registered dentist, and dispensed between the time
the premises close for dispensing and the time the premises open for
dispensing on a day other than a Sunday or a public holiday
|
713 (1756
non-resident
rate)
|
|
or
|
|
|
(ii) is endorsed ‘URGENT’ by the approved
medical practitioner or registered dentist, or ‘DISPENSED URGENTLY’ by the
approved supplier and is signed by the patient (or his representative) and
dispensed on a Sunday or a public holiday
|
920
(2118)
|
|
URGENT
FEES are not payable for prescriptions dispensed by an approved supplier when
his premises are open for dispensing in accordance with a scheme prepared by
the Committee under Article 4.
|
|
|
(g) items of pharmaceutical benefit the cost of which exceeds -
|
|
|
(i) £75 but
does not exceed £99.99
|
300
|
|
(ii) £100 but does not exceed £199.99
|
500
|
|
(iii) £200 but does not exceed £499.99
|
1000
|
|
(iv) £500
or over
|
2500
|
NOTES:
|
|
(1)
|
All ‘URGENT’
prescriptions must be endorsed by the approved supplier with the date and
time of dispensing.
|
|
(2)
|
In order to
qualify for the non-resident rates contained in sub-paragraph (f) an approved
supplier shall -
|
|
|
(a) normally live elsewhere than on his
business premises;
|
|
|
(b) have left those premises; and
|
|
|
(c) have
returned to open them to dispense an ‘URGENT’ prescription.
|
|
In the absence of
an endorsement ‘NON-RESIDENT’ on an ‘URGENT’ prescription, payment will
automatically be made at the ‘RESIDENT’ rate.
|
|
|
|
|
|
SCHEDULE 6
(Article 9(2))
Reduction of amount
payable to approved suppliers
Aggregate basic
ingredient price of pharmaceutical benefit supplied during month
|
Percentage by which basic
ingredient price reduced
|
exceeding
£
|
not exceeding
£
|
%
|
|
0
|
1,500
|
1.91
|
|
1,500
|
1,750
|
2.08
|
|
1,750
|
2,000
|
2.23
|
|
2,000
|
2,250
|
2.36
|
|
2,250
|
2,500
|
2.42
|
|
2,500
|
2,750
|
2.63
|
|
2,750
|
3,000
|
2.76
|
|
3,000
|
3,250
|
2.92
|
|
3,250
|
3,500
|
3.06
|
|
3,500
|
3,750
|
3.18
|
|
3,750
|
4,000
|
3.28
|
|
4,000
|
4,250
|
3.43
|
|
4,250
|
4,500
|
3.54
|
|
4,500
|
4,750
|
3.64
|
|
4,750
|
5,000
|
3.79
|
|
5,000
|
5,250
|
3.93
|
|
5,250
|
5,500
|
4.07
|
|
5,500
|
5,750
|
4.16
|
|
5,750
|
6,000
|
4.23
|
|
6,000
|
6,250
|
4.32
|
|
6,250
|
6,500
|
4.41
|
|
6,500
|
7,000
|
4.53
|
|
7,000
|
8,900
|
5.00
|
|
8,900
|
10,300
|
5.22
|
|
Aggregate basic
ingredient
price of pharmaceutical
benefit supplied
during month
|
Percentage by which basic
ingredient price reduced
|
exceeding
£
|
not exceeding
£
|
%
|
|
10,300
|
11,700
|
5.42
|
|
11,700
|
13,100
|
5.77
|
|
13,100
|
14,400
|
5.80
|
|
14,400
|
15,800
|
5.82
|
|
15,800
|
17,200
|
5.85
|
|
17,200
|
18,600
|
5.88
|
|
18,600
|
20,000
|
5.90
|
|
20,000
|
21,400
|
5.93
|
|
21,400
|
22,800
|
5.96
|
|
22,800
|
24,200
|
5.99
|
|
24,200
|
25,800
|
6.02
|
|
25,800
|
27,400
|
6.05
|
|
27,400
|
29,000
|
6.08
|
|
29,000
|
30,600
|
6.11
|
|
30,600
|
32,200
|
6.14
|
|
32,200
|
33,800
|
6.17
|
|
33,800
|
35,400
|
6.20
|
|
35,400
|
37,000
|
6.23
|
|
37,000
|
38,600
|
6.26
|
|
38,600
|
40,200
|
6.30
|
|
40,200
|
41,800
|
6.33
|
|
41,800
|
43,400
|
6.36
|
|
43,400
|
45,000
|
6.39
|
|
45,000
|
46,600
|
6.42
|
|
46,600
|
48,200
|
6.45
|
|
48,200
|
49,800
|
6.48
|
|
49,800
|
51,400
|
6.51
|
|
51,400
|
53,000
|
6.54
|
|
53,000
|
|
6.58
|
|